ASKAT INC.
Patent Owner
Stats
- 17 US PATENTS IN FORCE
- 2 US APPLICATIONS PENDING
- Dec 21, 2017 most recent publication
Details
- 17 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 289 Total Citation Count
- Apr 17, 1998 Earliest Filing
- 1 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0360,764 USE OF EP4 RECEPTOR ANTAGONISTS IN THE TREATMENT OF CARTILAGE DISEASEAug 04, 17Dec 21, 17[A61K, C07D]
2017/0253,595 SELECTIVE EP4 RECEPTOR ANTAGONISTIC SUBSTANCE FOR TREATMENT OF CANCERMay 23, 17Sep 07, 17[A61K, C07D, C07C]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9688674 Selective EP4 receptor antagonistic substance for treatment of cancerNov 19, 14Jun 27, 17[A61K, C07D, C07C]
9457084 Use of EP4 receptor antagonists in the treatment of IL-23 mediated diseasesFeb 22, 11Oct 04, 16[A61K, A01N, C07D]
8921391 Selective EP4 receptor antagonistic substance for treatment of cancerApr 22, 10Dec 30, 14[A61K, A01N, C07D, C07C]
8653063 N-substituted saturated heterocyclic sulfone compounds with CB2 receptor agonistic activityJan 22, 10Feb 18, 14[A61K, C07D, A61P]
7776885 Benzimidazolone compounds having 5-HT4 receptor agonistic activitySep 02, 04Aug 17, 10[A61K, C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0317,514 USE OF EP4 RECEPTOR ANTAGONISTS IN THE TREATMENT OF CARTILAGE DISEASEAbandonedMar 19, 14Nov 03, 16[A61K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.